Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2000
03/09/2000CA2337869A1 Method for labeling biopolymers using isotopes
03/09/2000CA2308309A1 Fraction collection system and method
03/09/2000CA2281035A1 Dsba/dsbb/dsbc/dsbd expression plasmid
03/09/2000CA2249657A1 Novel compounds
03/08/2000EP0984068A2 Sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0984067A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0984066A2 Activator for methanol dehydrogenase and gene thereof
03/08/2000EP0984065A1 Modified treponema pallidum-derived antigen protein
03/08/2000EP0984064A1 Novel dna fragments ordering gene expression predominant in flower organ
03/08/2000EP0984063A2 VEGF Related gene and protein
03/08/2000EP0984062A1 Production of human erythropoietin
03/08/2000EP0984061A1 Sialidases localized on plasma membranes and dna encoding the same
03/08/2000EP0984023A1 Cell surface molecule mediating cell adhesion and signal transmission
03/08/2000EP0983767A1 Preventives or remedies for sensitized t cell-related diseases containing il-6 antagonists as the active ingredient
03/08/2000EP0983513A1 Liposomes containing oligonucleotides
03/08/2000EP0983506A2 Functional expression of, and assay for, functional cellular receptors in vivo
03/08/2000EP0983391A1 Method for diagnosing alzheimer disease
03/08/2000EP0983390A1 Indirect genotypic method for diagnosing type 2 familial hemiplegic migraine
03/08/2000EP0983388A1 Method for detecting qualitative and quantitative alterations in dna and ligands of said alteration ligands
03/08/2000EP0983387A1 Methods for analyzing animal products
03/08/2000EP0983386A1 Method based on the use of bacteriophages for the detection biological molecules in biological samples
03/08/2000EP0983385A1 Prediction of inflammatory disease associated with il-1 geneloci polymorphisms
03/08/2000EP0983383A1 Length determination of nucleic acid repeat sequences by discontinuous primer extension
03/08/2000EP0983380A1 Methods for treating bipolar mood disorder associated with markers on chromosome 18q
03/08/2000EP0983379A1 Method and kit for the detection of mutations in dna's using restriction enzymes
03/08/2000EP0983372A1 Improved transaminase biotransformation process
03/08/2000EP0983371A1 Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male fertility and uses thereof in hybrid crop production
03/08/2000EP0983370A1 Gene silencing
03/08/2000EP0983369A1 In vivo modification of galactomannans in guar by expression of udp-galactose epimerase antisense rna
03/08/2000EP0983368A1 Cloning of udp-galactose epimerase
03/08/2000EP0983367A1 Enantioselective epoxide hydrolases and genes encoding these
03/08/2000EP0983366A2 Dna encoding an arthropod chitin synthase
03/08/2000EP0983365A1 Enzyme derived from thermophilic organisms that functions as a chromosomal replicase, and preparation and uses thereof
03/08/2000EP0983364A1 Dna polymerases having improved labeled nucleotide incorporation properties
03/08/2000EP0983363A1 Phosphatidyl-3,4.5-triphosphate-dependent protein kinase
03/08/2000EP0983362A1 Novel bacillus thuringiensis isolates active against sucking insects
03/08/2000EP0983361A1 Bacterial pheromones and uses therefor
03/08/2000EP0983360A1 Smad7 and uses thereof
03/08/2000EP0983359A1 DETECTION OF LOSS OF THE WILD-TYPE $i(hu)BUB1 GENE
03/08/2000EP0983358A1 New human dp1 homolog
03/08/2000EP0983357A1 Modulators of tissue regeneration
03/08/2000EP0983356A1 Smad2 phosphorylation and interaction with smad4
03/08/2000EP0983355A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
03/08/2000EP0983354A2 Neurotrophic factor receptors
03/08/2000EP0983353A1 Methods and compositions for diagnosis and treatment of cancer
03/08/2000EP0983352A1 Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen
03/08/2000EP0983351A1 Nucleic acid binding proteins
03/08/2000EP0983350A1 Nucleic acid binding proteins
03/08/2000EP0983349A1 Nucleic acid binding polypeptide library
03/08/2000EP0983348A2 Polyketides and their synthesis and use
03/08/2000EP0983333A1 Laundry and cleaning compositions containing xyloglucanase enzymes
03/08/2000EP0983302A1 Mutated okt3 antibody
03/08/2000EP0983293A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/08/2000EP0983292A1 Target-dependent reactions using structure-bridging oligonucleotides
03/08/2000EP0983290A1 Method for producing polymers having nucleo-bases as side-groups
03/08/2000EP0983078A1 SIALOADHESIN FAMILY 4 cDNA
03/08/2000EP0982988A1 Substantially pure zonulin, a physiological modulator of mammalian tight junctions
03/08/2000EP0833834B1 Dna sequence and encoded mammary-specific breast cancer protein
03/08/2000EP0804596A4 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4
03/08/2000EP0776160B1 Use of saponin for pathogen control
03/08/2000EP0722501B1 Cloned pullulanase
03/08/2000EP0693135B1 Fast dna sequence determination method and use thereof in sequencing and diagnostics
03/08/2000EP0672136B1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions
03/08/2000EP0656062B1 Dorsal tissue affecting factor and compositions
03/08/2000EP0619843B1 Icams immunoglobulin constant region soluble fusion proteins
03/08/2000CN1246923A ICAM-4 and diagnostic uses thereof
03/08/2000CN1246894A Transgenic potatoes having reduced levels of alpha glucan L- or H-type tuber phosphorylase activity with reduced cold-sweetening
03/08/2000CN1246893A Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides spp
03/08/2000CN1246892A Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
03/08/2000CN1246891A Polypeptide-polymer conjugates having added and/or removed attachment groups
03/08/2000CN1246869A Novel human 'beta' 2 integrin 'alpha' subunit
03/08/2000CN1246867A Helicobacter pylori live vaccine
03/08/2000CN1246799A Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
03/08/2000CN1246539A Bivalent disease-resistant carrier of chitinase and antibacterial peptide gene
03/08/2000CN1246538A Coding sequence of human ATP enzyme epsilon subunit, its encoded polypeptide and its preparing process
03/08/2000CN1246537A Coding sequence of human serine/threonine kinase II, its encoded polypeptide and its preparing process
03/08/2000CN1246536A Coding sequence of pyrophosphate synthetase, its encoded polypeptide and its preparing process
03/08/2000CN1246535A Coding sequence of human short-chain alcohol dehydrogenase, its encoded polypeptide and its preparing process
03/08/2000CN1246534A Coding sequence of human methionine sulfoxide reductase, its encoded polypeptide and its preparing process
03/08/2000CN1246533A Genomic sequence of human efficient lymphocyte chemotactic factor, its encoded polypeptide and its preparing process
03/08/2000CN1246532A Coding sequence of human heat shock associated protein, its encoded polypeptide and its preparing process
03/08/2000CN1246531A Human HSDHML coding sequence, its encoded polypeptide and its preparing process
03/08/2000CN1246530A Human gene coding sequence, its encoded polypeptide and its preparing process
03/08/2000CN1246529A Coding sequence of human translation initiation factor subunit, its encoded polypeptide and its preparing process
03/07/2000US6034298 The vaccine is administered through the consumption of the edible plant as food, preferably in the form of a fruit or vegetable juice which can be taken orally.
03/07/2000US6034235 Growth inhibitor for leukemia cell comprising antisense oligonucleotide derivative to wilms tumor gene (WT1)
03/07/2000US6034234 Double-stranded oligonucleotide and anticancer agent containing the same as active ingredient
03/07/2000US6034233 2'-O-alkylated oligoribonucleotides and phosphorothioate analogs complementary to portions of the HIV genome
03/07/2000US6034232 The stress response of the body to ischemic hypoxia is an active phenomenon involving protein neogenesis.
03/07/2000US6034231 Human CNP gene and precursor protein
03/07/2000US6034230 Modulate inflammatory heart disease.
03/07/2000US6034229 BMP-15 compositions
03/07/2000US6034224 Contacting a somatotropin with a c 10-18 acylglutamate detergent composition and water and adjusting the ph of the somatotropin solution
03/07/2000US6034223 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof
03/07/2000US6034222 Method for the separation of recombinant pro-factor IX from recombinant factor IX
03/07/2000US6034221 Reduced side effects
03/07/2000US6034219 Human macrophage antigen
03/07/2000US6034217 Peptidoglycan recognition proteins and their production
03/07/2000US6034212 SH3 kinase domain associated protein, a signalling domain therein, nucleic acids encoding the protein and the domain, and diagnostic and therapeutic uses thereof
03/07/2000US6034137 Cationic lipids for gene therapy